Research Article
Predictors of Treatment Outcomes among Multidrug Resistant Tuberculosis Patients in Tanzania
Table 6
Adjusted OR after multivariate analysis for predictors of treatment outcome of loss to follow-up.
| | Characteristics | Loss to follow up | Other treatment categories | aOR(95% CI) | p-value | | N (%) | N (%) |
| | Residence | | | | | | (i) Other | 7(4.3) | 154(95.7) | 2.41(0.84-6.91) | 0.102 | | (ii) Dar | 16(9.4) | 155(90.6) | | |
| | Diabetes | | | | | | (i) Yes | 1(20.0) | 4(80.0) | 0.29(0.04-2.08) | 0.216 | | (ii) No | 19(8.9) | 295(91.1) | | |
| | Smoking | | | | | | (i) Yes | 6(7.7) | 72(92.3) | 0.74(0.32-1.77) | 0.509 | | (ii) No | 5(4.6) | 104(95.4) | | |
| | HIV status | | | | | | (i) Yes | 8(6.9) | 108(93.1) | 0.96(0.34-2.76) | 0.943 | | (ii) No | 15(6.9) | 201(93.1) | | |
| | Alcohol use | | | | | | (i) Yes | 9(9.5) | 86(90.5) | 1.61(0.72-3.56) | 0.244 | | (ii) No | 5(5.3) | 89(94.7) | | |
| | Isoniazid | | | | | | (i) Resistant | 9(7.4) | 121(92.6) | 1.22(0.32-4.68) | 0.768 | | (ii) Susceptible | 1(9.1) | 10(90.9) | | |
| | Rifampicin | | | | | | (i) Resistant | 14(6.9) | 188(93.1) | 0.93(0.25-3.44) | 0.909 | | (ii) Susceptible | 0(0.0) | 5(100.0) | | |
| | Streptomycin | | | | | | (i) Resistant | 7(8.8) | 73(91.2) | 0.14(0.02-1.14) | 0.066 | | (ii) Susceptible | 1(2.9) | 33(97.1) | | |
| | Ethambutol | | | | | | (i) Resistant | 4(5.5) | 69(94.5) | 4.65(0.88-24.56) | 0.070 | | (ii) Susceptible | 4(10.8) | 33(89.2) | | |
|
|
